BRIEF published on 12/13/2024 at 08:10, 1 year 4 months ago Nyxoah lance la thérapie Genio® en Angleterre Apnée Obstructive Du Sommeil Nyxoah SA Lancement Sur Le Marché Thérapie Genio® Service National De Santé D'Angleterre
BRIEF published on 12/13/2024 at 08:10, 1 year 4 months ago Nyxoah Launches Genio® Therapy in England NHS England Obstructive Sleep Apnea Nyxoah SA Market Launch Genio® Therapy
PRESS RELEASE published on 12/13/2024 at 08:05, 1 year 4 months ago Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England Nyxoah announces commercial launch of Genio Innovative Therapy in England with successful implants at UCLH. Genio system covered under NHS SSDP for OSA patients Nyxoah Genio Innovative Therapy England OSA
BRIEF published on 11/06/2024 at 22:10, 1 year 6 months ago Nyxoah publie ses résultats financiers du troisième trimestre 2024 Résultats Financiers Approbation De La FDA Situation De Trésorerie Apnée Obstructive Du Sommeil Commercialisation Aux États-Unis
BRIEF published on 11/06/2024 at 22:10, 1 year 6 months ago Nyxoah Reports Third Quarter 2024 Financial Results Financial Results Cash Position FDA Approval Obstructive Sleep Apnea U.S. Commercialization
PRESS RELEASE published on 11/06/2024 at 22:05, 1 year 6 months ago Nyxoah Reports Third Quarter Financial and Operating Results Nyxoah SA reports third quarter financial and operating results, with FDA approval on track for Q1 2025 and strengthening of U.S. commercial team. Company fully funded until mid-2026 Financial Results FDA Approval Sleep Apnea Nyxoah U.S. Commercial Team
BRIEF published on 10/08/2024 at 14:05, 1 year 7 months ago Nyxoah Secures $27 Million in At-the-Market Offering Financing U.S. Market Nyxoah Neuromodulation Healthcare Investor
BRIEF published on 10/08/2024 at 14:05, 1 year 7 months ago Nyxoah obtient 27 millions de dollars lors d'une offre sur le marché Financement Marché Américain Nyxoah Neuromodulation Investisseur Dans Le Secteur De La Santé
PRESS RELEASE published on 10/08/2024 at 14:00, 1 year 7 months ago Nyxoah Raises $27 Million through its At-the-Market Offering Nyxoah raises $27 million through its At-the-Market Offering, strengthening balance sheet and U.S. focus. New investment from U.S. healthcare investor Financing At-the-market Offering Nyxoah Obstructive Sleep Apnea Healthcare Investor
BRIEF published on 09/27/2024 at 22:35, 1 year 7 months ago Nyxoah présente les données prometteuses de l'étude DREAM à l'ISSS 2024 Approbation De La FDA Apnée Obstructive Du Sommeil Données Cliniques Étude DREAM Stimulation Génio
Published on 05/09/2026 at 01:30, 20 hours 20 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 21 hours 50 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 2 hours 44 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 1 hour ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 2 hours ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 2 hours ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days 2 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 2 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 2 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 2 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 2 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
